Thyroid tablets recalled nationwide over potential 'superpotency': FDA
Patients taking the affected lot are advised not to discontinue use without first consulting their health care provider.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on thehill.com — the content belongs to The Hill.
